Immix Biopharma Inc (IMMX) Implied Volatility Current

Tracking IMMX implied volatility helps you identify when options premiums on Immix Biopharma Inc are historically cheap or expensive, and where the best trades are hiding. Immix Biopharma Inc implied volatility reflects the market's expectation of future price movement: when IMMX IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Immix Biopharma Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For IMMX, tracking metrics like IMMX IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on IMMX signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specific biologic for the treatment of colorectal cancers; and IMX-120, a tissue-specific biologic for the treatment of ulcerative colitis and severe Crohn's disease. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab.

The company was incorporated in 2012 and is headquartered in Los Angeles, California.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where IMMX implied volatility sits today versus where it has been. Our scanner ranks Immix Biopharma Inc implied volatility against its historical range, surfaces extremes in IMMX IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Immix Biopharma Inc IV is rich or cheap — measure it, then act on it.